Lilah Toker
- Biological Psychiatry top 5%
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments 5
-
- Neuroscience and Neuropharmacology Research 5
- Genetic Neurodegenerative Diseases 3
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments 5
- Behavioral Neuroscience top 10%
-
- Bipolar Disorder and Treatment 9
-
- Genetics and Neurodevelopmental Disorders 6
-
- RNA Research and Splicing 4
- Single-cell and spatial transcriptomics 3
- Mitochondrial Function and Pathology 3
Lilah Toker
26 papers receiving 749 citations
Peers
Comparison fields: 5 of 89
- Biological Psychiatry 98
- Neurology 97
- Cellular and Molecular Neuroscience 200
- Neurology 156
- Behavioral Neuroscience 36
Countries citing papers authored by Lilah Toker
This map shows the geographic impact of Lilah Toker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilah Toker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilah Toker more than expected).
Fields of papers citing papers by Lilah Toker
This network shows the impact of papers produced by Lilah Toker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilah Toker. The network helps show where Lilah Toker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lilah Toker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 19 | |
| 3 | 2022 | 51 | |
| 4 | 2021 | 84 | |
| 5 | 2020 | 35 | |
| 6 | 2020 | 4 | |
| 7 | 2019 | 9 | |
| 8 | 2018 | 76 | |
| 9 | 2018 | 21 | |
| 10 | 2017 | 90 | |
| 11 | 2017 | 35 | |
| 12 | 2017 | 1 | |
| 13 | 2016 | 40 | |
| 14 | 2015 | 32 | |
| 15 | 2014 | 15 | |
| 16 | 2013 | 9 | |
| 17 | 2013 | 65 | |
| 18 | 2013 | 7 | |
| 19 | 2013 | 37 | |
| 20 | 2012 | 14 |
About Lilah Toker
Lilah Toker is a scholar working on Biological Psychiatry, Cellular and Molecular Neuroscience and Psychiatry and Mental health, having authored 27 papers that have together received 757 indexed citations. Recurring topics across this work include Bipolar Disorder and Treatment (9 papers), Genetics and Neurodevelopmental Disorders (6 papers), Neuroscience and Neuropharmacology Research (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), RNA Research and Splicing (4 papers), Single-cell and spatial transcriptomics (3 papers), Mitochondrial Function and Pathology (3 papers) and Genetic Neurodegenerative Diseases (3 papers). The work is most often cited by research in Biological Psychiatry (98 citations), Neurology (97 citations) and Cellular and Molecular Neuroscience (200 citations). Lilah Toker has collaborated with scholars based in Israel, Canada and Norway. Frequent co-authors include Galila Agam, B. Ogan Mancarci, Paul Pavlidis, Shreejoy J. Tripathy, Charalampos Tzoulis, Kristoffer Haugarvoll, Yuly Bersudsky, Haim Einat, Brenna Li and Gonzalo S. Nido. Their work appears in journals such as Nature Communications, Scientific Reports and Biological Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.